ResearcherHeidelberg UniversityNo recent work listed
Xuefeng An
Matched on OpenAlex author ID A5000812114. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2021: 2 papers · 2022: 3 papers · 2023: 1 paper
Papers 6
- Corrigendum to: "Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death" [Biomed. Pharmacother. 153 (2… First author DOI 10.1016/j.biopha.2023.115879↗
- Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death. First author DOI 10.1016/j.biopha.2022.113511↗
- Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.matbio.2022.11.002↗
- Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy. Co-author DOI 10.1038/s41419-022-05503-3↗
- Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Progression. Co-author DOI 10.3390/cancers13040827↗
- Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer. Co-author DOI 10.3390/cancers13194770↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ingrid Herr · 6 shared papers, 2021–2023 · strength 0.88
- Paper Corrigendum to: "Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of c… DOI 10.1016/j.biopha.2023.115879↗
- Paper Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death. DOI 10.1016/j.biopha.2022.113511↗
- Paper Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy. DOI 10.1038/s41419-022-05503-3↗
- Bin Yan · 5 shared papers, 2021–2023 · strength 0.74
- Paper Corrigendum to: "Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of c… DOI 10.1016/j.biopha.2023.115879↗
- Paper Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death. DOI 10.1016/j.biopha.2022.113511↗
- Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
- Michael Schaefer · 4 shared papers, 2021–2023 · strength 0.62
- Paper Corrigendum to: "Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of c… DOI 10.1016/j.biopha.2023.115879↗
- Paper Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death. DOI 10.1016/j.biopha.2022.113511↗
- Paper Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy. DOI 10.1038/s41419-022-05503-3↗
- Yiqiao Luo · 3 shared papers, 2021–2022 · strength 0.38
- Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
- Paper Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Pr… DOI 10.3390/cancers13040827↗
- Paper Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pan… DOI 10.3390/cancers13194770↗
- Li Liu · 3 shared papers, 2021–2022 · strength 0.38
- Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
- Paper Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Pr… DOI 10.3390/cancers13040827↗
- Paper Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pan… DOI 10.3390/cancers13194770↗
- Li Liu · 1 shared paper, 2023 · strength 0.19
- Li Liu · 1 shared paper, 2022 · strength 0.16
- Li Liu · 1 shared paper, 2022 · strength 0.14
- Xi Xiao · 1 shared paper, 2022 · strength 0.14
- Oliver Strobel · 1 shared paper, 2022 · strength 0.14
- Franco Fortunato · 1 shared paper, 2022 · strength 0.13
- Matthias M. Gaida · 1 shared paper, 2022 · strength 0.13
- Lian Zhao · 1 shared paper, 2022 · strength 0.13
- Libo Yin · 1 shared paper, 2021 · strength 0.13
- Kangtao Wang · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.